Study Demonstrates Benefits Of MicroPulse™ Photocoagulation Over Current Standard Laser Treatment Of Diabetic Macular Edema
IRIDEX Corporation (Nasdaq: IRIX) announced that leading clinicians have performed and published the results of a new study* that compares the benefits of MicroPulse photocoagulation technology, similar to that used in the new generation IRIDEX lasers, over the standard-of-care protocol for the treatment of eyes with diabetic macular edema (DME)...